NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 256 filers reported holding NEOGENOMICS INC in Q2 2019. The put-call ratio across all filers is 0.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $6,558,000 | +3.7% | 135,942 | -2.9% | 0.58% | +4.7% |
| Q2 2021 | $6,325,000 | -58.1% | 140,037 | -55.2% | 0.55% | -60.7% |
| Q1 2021 | $15,089,000 | -12.3% | 312,855 | -2.1% | 1.40% | -7.4% |
| Q4 2020 | $17,214,000 | +13.6% | 319,718 | -22.2% | 1.52% | +28.7% |
| Q3 2020 | $15,151,000 | +12.4% | 410,717 | -5.6% | 1.18% | +4.2% |
| Q2 2020 | $13,477,000 | +3.9% | 435,018 | -7.4% | 1.13% | -14.8% |
| Q1 2020 | $12,970,000 | -17.7% | 469,766 | -12.8% | 1.33% | +14.8% |
| Q4 2019 | $15,764,000 | +59.6% | 538,950 | +4.3% | 1.16% | +55.7% |
| Q3 2019 | $9,875,000 | -16.2% | 516,502 | -3.8% | 0.74% | -8.7% |
| Q2 2019 | $11,779,000 | – | 536,865 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,785,605 | $86,138,000 | 34.19% |
| PERKINS CAPITAL MANAGEMENT INC | 157,750 | $7,610,000 | 4.71% |
| Blue Water Life Science Advisors, LP | 222,222 | $10,719,000 | 3.49% |
| First Light Asset Management, LLC | 1,055,960 | $50,940,000 | 3.36% |
| Ranger Investment Management | 810,956 | $39,121,000 | 2.09% |
| Bullseye Asset Management LLC | 108,054 | $5,212,000 | 1.81% |
| Lombard Odier Asset Management (Switzerland) SA | 584,281 | $28,186,000 | 1.75% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 998,858 | $48,185,000 | 1.67% |
| EMERALD ADVISERS, LLC | 904,298 | $43,623,000 | 1.58% |
| Soleus Capital Management, L.P. | 190,556 | $9,192,000 | 1.43% |